A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells

Hans Joachim Wagner, Catherine M. Bollard, Stéphane Vigouroux, M. Helen Huls, Robert Anderson, H. Grant Prentice, Malcolm Brenner, Helen Heslop, Cliona M. Rooney

Research output: Contribution to journalArticle

64 Scopus citations

Fingerprint Dive into the research topics of 'A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells'. Together they form a unique fingerprint.

Medicine & Life Sciences